The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
![ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/images/default-source/default-album/icr-rmh-clarivate-highly-cited-researchers-2021-2-945x532.tmb-0945x532.jpg?sfvrsn=3d922b69_1)
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
![World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology](https://www.chrisnutting-oncology.co.uk/cms/wp-content/uploads/2022/01/royalmarsden_67975358223_0-500x333.jpeg)
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
![Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/researchers/kevin-harrington-appearing-on-bbc-panorama.jpg?sfvrsn=a7226f69_2)
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
![Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY](https://embed-ssl.wistia.com/deliveries/29642f5bcb5b4ae4922d93c53e4f68e7.webp?image_crop_resized=1280x720)
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
![The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a](https://pbs.twimg.com/media/FCTe35EX0AAn_Tc.png)